This innovative biotechnology company was founded in 2012 as a spin-out of the Institute for Molecular Microbiology and Biotechnology of the Westfälische Wilhelms-Universität in Münster. Cysal is active in the production of biopolymers, peptides, and especially dipeptides. Furthermore, Cysal specializes in developing biotechnology solutions in General.


Dr. Martin Krehenbrink

Ahmed Sallam

Press releases

Gründerfonds Münsterland and HTGF II Invest in Cysal GmbH

As part of seed financing eCAPITAL entrepreneurial Partners AG’s Gründerfonds Münsterland and High-Tech Gründerfonds II (HTGF) have made a seven-figure investment in Cysal GmbH. The spin-off from University of Münster (WWU) will use the funds raised to accelerate business development, set up biotechnological…

Info & Contact

Ahmed Sallam


Technologiehof Münster
Mendelstraße 11
48149 Münster

In portfolio

27. Jun 2012